• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧合酶缺失小鼠中 EP4 受体的激活限制了急性心力衰竭向慢性心力衰竭的转变。

Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.

机构信息

Division of Cardiovascular Sciences, Department of Medicine, University of South Florida.

Division of Nephrology, The University of Alabama at Birmingham, Alabama.

出版信息

Theranostics. 2021 Jan 1;11(6):2742-2754. doi: 10.7150/thno.51183. eCollection 2021.

DOI:10.7150/thno.51183
PMID:33456570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806484/
Abstract

Immune responsive 12/15 lipoxygenase (12/15LOX)-orchestrate biosynthesis of essential inflammation-resolution mediators during acute inflammatory response in post-myocardial infarction (MI). Lack of 12/15LOX dampens proinflammatory mediator 12-(S)-hydroxyeicosatetraenoic acid (12-(S)-HETE), improves post-MI survival, through the biosynthesis of endogenous mediators epoxyeicosatrienoic acids (EETs; cypoxins) to resolve post-MI inflammation. However, the mechanism that amplifies cypoxins-directed cardiac repair in acute heart failure (AHF) and chronic HF (CHF) remains of interest in MI-directed renal inflammation. Therefore, we determined the role of EETs in macrophage-specific receptor activation in facilitating cardiac repair in 12/15LOX deficient mice experiencing HF. Risk-free young adult (8 -12 week-old) male C57BL/6J wild-type mice (WT; n = 43) and 12/15LOX mice (n = 31) were subjected to permanent coronary artery ligation and monitored at day (d)1, d5 (as acute HF), and d28 to d56 (8 weeks; chronic HF) post-surgery maintaining no-MI mice that served as d0 naïve controls. Left ventricle (LV) infarcted area of 12/15LOX mice displayed an increase in expression of prostanoid receptor EP4 along with monocyte chemoattractant protein-1 CCL2 in AHF and CHF. The transcriptome analysis of isolated leukocytes (macrophages/neutrophils) from infarcted LV revealed a higher expression of EP4 on reparative macrophages expressing in 12/15LOX mice. Deletion of 12/15LOX differentially modulated the miRNA levels, downregulating miR-23a-3p (20 fold; < 0.05) and upregulating miR-125a-5p (160 fold; < 0.05) in AHF which promoted polarization of the macrophages towards reparative phenotype. Furthermore, 12/15LOX deletion markedly attenuated renal inflammation with reduced levels of NGAL and KIM-1 and apoptotic markers in the kidney during CHF. In risk-free mice during physiological cardiac repair, absence of 12/15LOX promoted reparative macrophages with marked activation of EP4 signaling thereby improving post-MI survival and limiting renal inflammation in acute and advanced HF. The future studies are warranted to advance the role of EETs in macrophage receptor biology.

摘要

免疫反应性 12/15 脂氧合酶(12/15LOX)-协调心肌梗死后(MI)急性炎症反应中必需的炎症解决介质的生物合成。缺乏 12/15LOX 会抑制促炎介质 12-(S)-羟基二十碳四烯酸(12-(S)-HETE),通过生物合成内源性介质环氧二十碳三烯酸(EETs;cypoxins)来改善 MI 后炎症,从而提高 MI 后存活率。然而,在急性心力衰竭(AHF)和慢性心力衰竭(CHF)中,增强 cypoxins 靶向心脏修复的机制仍然是 MI 靶向肾炎症的研究热点。因此,我们在经历 HF 的 12/15LOX 缺陷小鼠中确定了 EETs 在巨噬细胞特异性受体激活中促进心脏修复的作用。无风险的成年雄性 C57BL/6J 野生型(WT;n = 43)和 12/15LOX 小鼠(n = 31)被置于永久性冠状动脉结扎下,并在手术后第 1 天(d1)、第 5 天(急性 HF)和第 28 天至第 56 天(慢性 HF)进行监测,维持无 MI 作为 d0 未致敏对照。12/15LOX 小鼠的左心室(LV)梗死面积显示,在 AHF 和 CHF 中,前列腺素受体 EP4 的表达增加,同时单核细胞趋化蛋白-1 CCL2 的表达增加。从梗死 LV 分离的白细胞(巨噬细胞/中性粒细胞)的转录组分析显示,在 12/15LOX 小鼠中,表达的修复性巨噬细胞上 EP4 的表达更高。12/15LOX 的缺失差异调节了 miRNA 水平,下调 miR-23a-3p(20 倍; < 0.05)并上调 miR-125a-5p(160 倍; < 0.05)在 AHF 中促进了巨噬细胞向修复表型的极化。此外,在 CHF 期间,12/15LOX 的缺失显著减轻了肾脏炎症,降低了肾脏中的 NGAL 和 KIM-1 以及凋亡标志物的水平。在生理心脏修复期间的无风险小鼠中,缺乏 12/15LOX 促进了具有显著 EP4 信号激活的修复性巨噬细胞,从而提高了 MI 后的存活率,并限制了急性和晚期 HF 中的肾脏炎症。需要进一步的研究来推进 EETs 在巨噬细胞受体生物学中的作用。

相似文献

1
Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.环氧合酶缺失小鼠中 EP4 受体的激活限制了急性心力衰竭向慢性心力衰竭的转变。
Theranostics. 2021 Jan 1;11(6):2742-2754. doi: 10.7150/thno.51183. eCollection 2021.
2
Macrophage-specific lipoxygenase deletion amplify cardiac repair activating Treg cells in chronic heart failure.巨噬细胞特异性脂氧合酶缺失可扩增慢性心力衰竭心脏修复激活的 Treg 细胞。
J Leukoc Biol. 2024 Oct 1;116(4):864-875. doi: 10.1093/jleuko/qiae113.
3
Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.基因敲除 12/15 脂氧合酶可促进心肌梗死后炎症的有效消退。
J Mol Cell Cardiol. 2018 May;118:70-80. doi: 10.1016/j.yjmcc.2018.03.004. Epub 2018 Mar 8.
4
Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing.12/15-脂氧合酶与脂肪酸的相互作用改变白细胞动力学,从而改善心肌梗死后的愈合。
Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H89-H102. doi: 10.1152/ajpheart.00040.2017. Epub 2017 Apr 14.
5
Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure.脂氧合酶驱动缺血性心力衰竭中的脂质组学和代谢重编程。
Metabolism. 2019 Jul;96:22-32. doi: 10.1016/j.metabol.2019.04.011. Epub 2019 Apr 15.
6
Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure.脂氧合酶抑制剂 ML351 失调固有炎症反应,导致急性心力衰竭中心脏修复受损。
Biomed Pharmacother. 2021 Jul;139:111574. doi: 10.1016/j.biopha.2021.111574. Epub 2021 Apr 13.
7
Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.抑制 FPR2 可损害白细胞募集并引发急性心力衰竭中的非解决性炎症。
Pharmacol Res. 2019 Aug;146:104295. doi: 10.1016/j.phrs.2019.104295. Epub 2019 Jun 16.
8
Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation.衰老与脂氧合酶缺乏的相互作用会引发脾肿大、心脏功能障碍和严重的白细胞导向非解决性炎症。
Geroscience. 2022 Jun;44(3):1689-1702. doi: 10.1007/s11357-021-00496-x. Epub 2021 Dec 21.
9
Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.免疫反应性 resolvin D1 可改善心力衰竭所致心肌梗死后心肾综合征。
FASEB J. 2018 Jul;32(7):3717-3729. doi: 10.1096/fj.201701173RR. Epub 2018 Feb 13.
10
Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.免疫反应性 resolvin D1 可调节代谢微环境中腹腔巨噬细胞和心肌成纤维细胞的表型。
J Cell Physiol. 2019 Apr;234(4):3910-3920. doi: 10.1002/jcp.27165. Epub 2018 Sep 7.

引用本文的文献

1
Leukocyte-type 12/15-lipoxygenase is essential for timely inflammation-resolution and effective tissue regeneration following skeletal muscle injury.白细胞型12/15-脂氧合酶对于骨骼肌损伤后及时的炎症消退和有效的组织再生至关重要。
Mol Metab. 2025 Aug 5;100:102224. doi: 10.1016/j.molmet.2025.102224.
2
Leukocyte-type 12/15-lipoxygenase is essential for timely inflammation-resolution and effective tissue regeneration following skeletal muscle injury.白细胞型12/15-脂氧合酶对于骨骼肌损伤后及时的炎症消退和有效的组织再生至关重要。
bioRxiv. 2025 May 17:2025.05.13.653766. doi: 10.1101/2025.05.13.653766.
3
Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β-Adrenergic Activation.

本文引用的文献

1
Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice.雄性和雌性小鼠心脏修复的分子和细胞差异。
J Am Heart Assoc. 2020 Apr 21;9(8):e015672. doi: 10.1161/JAHA.119.015672. Epub 2020 Apr 16.
2
MicroRNAs as Molecular Switches in Macrophage Activation.MicroRNAs 作为巨噬细胞活化的分子开关。
Front Immunol. 2019 Apr 17;10:799. doi: 10.3389/fimmu.2019.00799. eCollection 2019.
3
Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure.脂氧合酶驱动缺血性心力衰竭中的脂质组学和代谢重编程。
靶向E前列腺素受体EP4可减轻β-肾上腺素能激活诱导的心脏纤维化。
Adv Sci (Weinh). 2025 Mar;12(12):e2413324. doi: 10.1002/advs.202413324. Epub 2025 Feb 7.
4
Genetic deletion of 12/15 lipoxygenase delays vascular remodeling and limits cardiorenal dysfunction after pressure overload.12/15脂氧合酶的基因缺失可延缓压力超负荷后的血管重塑并限制心肾功能障碍。
J Mol Cell Cardiol Plus. 2023 Aug 19;5:100046. doi: 10.1016/j.jmccpl.2023.100046. eCollection 2023 Sep.
5
MiR-21-3p inhibitor exerts myocardial protective effects by altering macrophage polarization state and reducing excessive mitophagy.miR-21-3p 抑制剂通过改变巨噬细胞极化状态和减少过度自噬发挥心肌保护作用。
Commun Biol. 2024 Oct 22;7(1):1371. doi: 10.1038/s42003-024-07050-3.
6
Bioinformatics analysis of neutrophil-associated hub genes and ceRNA network construction in septic cardiomyopathy.脓毒性心肌病中性粒细胞相关枢纽基因的生物信息学分析及 ceRNA 网络构建。
Aging (Albany NY). 2024 Aug 30;16(19):12833-12849. doi: 10.18632/aging.206092.
7
Macrophage-specific lipoxygenase deletion amplify cardiac repair activating Treg cells in chronic heart failure.巨噬细胞特异性脂氧合酶缺失可扩增慢性心力衰竭心脏修复激活的 Treg 细胞。
J Leukoc Biol. 2024 Oct 1;116(4):864-875. doi: 10.1093/jleuko/qiae113.
8
Extrinsic and intrinsic modulators of inflammation-resolution signaling in heart failure.心力衰竭中炎症消退信号的外在和内在调节因子。
Am J Physiol Heart Circ Physiol. 2023 Sep 1;325(3):H433-H448. doi: 10.1152/ajpheart.00276.2023. Epub 2023 Jul 7.
9
The Role of ncRNAs in Cardiac Infarction and Regeneration.非编码RNA在心肌梗死与再生中的作用
J Cardiovasc Dev Dis. 2023 Mar 15;10(3):123. doi: 10.3390/jcdd10030123.
10
MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4.微小RNA通过上调核因子κB信号通路相关的组蛋白去乙酰化酶7/辅肌动蛋白4促进脓毒症诱导的心肌病和神经血管功能障碍的进展。
Front Neurol. 2022 Jun 9;13:909828. doi: 10.3389/fneur.2022.909828. eCollection 2022.
Metabolism. 2019 Jul;96:22-32. doi: 10.1016/j.metabol.2019.04.011. Epub 2019 Apr 15.
4
Prostaglandin E Receptor 2 Modulates Macrophage Activity for Cardiac Repair.前列腺素 E 受体 2 调节巨噬细胞活性以促进心脏修复。
J Am Heart Assoc. 2018 Oct 2;7(19):e009216. doi: 10.1161/JAHA.118.009216.
5
Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.免疫反应性 resolvin D1 可调节代谢微环境中腹腔巨噬细胞和心肌成纤维细胞的表型。
J Cell Physiol. 2019 Apr;234(4):3910-3920. doi: 10.1002/jcp.27165. Epub 2018 Sep 7.
6
Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.卡洛芬亚急性治疗可改善心脏损伤所致的心脾缓解缺陷。
J Leukoc Biol. 2018 Dec;104(6):1173-1186. doi: 10.1002/JLB.3A0618-223R. Epub 2018 Aug 26.
7
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment.抗炎性微小RNA及其在炎症性疾病治疗中的潜力。
Front Immunol. 2018 Jun 25;9:1377. doi: 10.3389/fimmu.2018.01377. eCollection 2018.
8
MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.微小 RNA-378 通过机械压力后心脏肥大早期的旁分泌机制抑制心肌纤维化。
Theranostics. 2018 Apr 3;8(9):2565-2582. doi: 10.7150/thno.22878. eCollection 2018.
9
Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.基因敲除 12/15 脂氧合酶可促进心肌梗死后炎症的有效消退。
J Mol Cell Cardiol. 2018 May;118:70-80. doi: 10.1016/j.yjmcc.2018.03.004. Epub 2018 Mar 8.
10
Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.前列腺素 E2 EP4 受体过表达改善心肌梗死后的心脏功能。
J Mol Cell Cardiol. 2018 May;118:1-12. doi: 10.1016/j.yjmcc.2018.03.005. Epub 2018 Mar 6.